课题基金 / 基金详情

Characterisation of novel regulators of the haemopoeitic system.

Characterisation of novel regulators of the haemopoeitic system.
造血系统新型调节剂的表征。
批准号:
nhmrc : 110298
负责人:
Prof Peter Klinken
金额:
$25.45万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2000
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2000-01-01 至 2002-12-31

项目摘要

项目成果

Prof Peter Klinken的其他基金

相似基金

相关文献

中文摘要
翻译
所有循环中的血细胞(包括红细胞和白细胞)都是从成人骨髓中发现的一种称为造血干细胞(HSC)的单一细胞类型发展而来的。正常情况下,HSC会逐渐被限制为只成为一种细胞类型,一旦它们沿着该途径开始,就不能再产生另一种途径的细胞(例如,一旦HSC开始发育成红细胞,它们通常不能改变方向成为白细胞)。然而,有几个成熟细胞的例子改变了途径。我们已经使用了其中之一,小鼠的J2E红细胞转化为巨噬细胞,来识别参与这一过程的基因。我们发现的两个基因,HLS5和HLS7,在谱系决定和正常血液发育以及血癌的形成方面具有潜在的重要作用。该项目旨在研究这些基因在血液发育中所起的作用。到目前为止,我们的大部分工作都集中在HLS7上。人类等同于HLS7的基因是由一个独立于我们的美国组织发现的,它是一种导致一种血癌的基因。我们已经证明,HLS7对正常的血液发育有显著的影响,这些结果清楚地表明了该基因的重要性。通过我们对HLS7作用机制的研究,我们发现了另一个基因M44,它可能在HLS7的调控中起重要作用,并计划研究其功能。最后,HLS5与一组被称为转录因子的分子有相似之处,后者被认为是调节血液发育的关键因素。显然,对该基因的分析将进一步加深我们在这一领域的知识。
英文摘要
All of the circulating blood cells (including red cells and white cells) develop from a single cell type, called the haemopoietic stem cell (HSC), found in the adult bone marrow. Normally, HSCs are gradually restricted to become only one cell type and once they have started down that pathway can no longer generate cells of another pathway (e.g. once HSC begin to develop into red blood cells, they cannot normally change their direction to become white cells). There are a few examples of mature cells, however, that have changed pathways. We have use one of these, the mouse J2E red cell changing into macrophages, to identify the genes involved in this process. Two of the genes we found, HLS5 and HLS7, are potentially important in lineage determination and normal blood development as well as the formation of blood cancers. This project aims to investigate the roles these genes play in blood development. Much of our work to date has focused on HLS7. The human equivalent of HLS7 was found by an American group independently of us as a gene which causes one type of blood cancer. We have shown HLS7 has dramatic effects on normal blood development and, together, these results clearly show the importance of this gene. Through our studies on how HLS7 works, we have identified another gene, M44, which may be important in regulation of HLS7 and also plan to investigate is function. Finally, HLS5 has similarities to a group of molecules called transcription factors which are known to be key regulators blood development. Clearly, analysis of this gene will further our knowledge in this field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHARACTERIZATION OF THE NOVEL LEUKEMIA-INDUCING GENE MLF1
  • 批准号:
    nhmrc : 254668
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $26.26万
  • 财政年份:
    2003
  • 负责人:
    Prof Peter Klinken
  • 依托单位:
Characterization of HLS5, a novel tumor suppressor gene
  • 批准号:
    nhmrc : 212070
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $27.14万
  • 财政年份:
    2002
  • 负责人:
    Prof Peter Klinken
  • 依托单位:
Novel regulators of erythropoiesis identified by yeast two hybrid screening
  • 批准号:
    nhmrc : 980610
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $12.24万
  • 财政年份:
    1998
  • 负责人:
    Prof Peter Klinken
  • 依托单位:
Genes that control blood cell production
  • 批准号:
    nhmrc : 970095
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $11.64万
  • 财政年份:
    1997
  • 负责人:
    Prof Peter Klinken
  • 依托单位:
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: